Celldex (CLDX) Misses Q4 EPS by 7c

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.83), $0.07 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $4.13 million versus the consensus estimate of $855.71 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Pan American Silver (PAAS) Misses Q2 EPS by 19c